1. Home
  2. LABT vs MI Comparison

LABT vs MI Comparison

Compare LABT & MI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$0.20

Market Cap

670.6K

Sector

Health Care

ML Signal

N/A

Logo NFT Limited

MI

NFT Limited

N/A

Current Price

$0.39

Market Cap

546.6K

ML Signal

N/A

Company Overview

Basic Information
Metric
LABT
MI
Founded
2006
2009
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
670.6K
546.6K
IPO Year
2026
2022

Fundamental Metrics

Financial Performance
Metric
LABT
MI
Price
$0.20
$0.39
Analyst Decision
Analyst Count
0
0
Target Price
★ $7.50
N/A
AVG Volume (30 Days)
607.7K
★ 9.7M
Earning Date
11-18-2026
12-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.18
52 Week High
$6.85
$19.84

Technical Indicators

Market Signals
Indicator
LABT
MI
Relative Strength Index (RSI) 16.87 40.14
Support Level N/A $0.22
Resistance Level $2.13 $4.59
Average True Range (ATR) 0.06 0.07
MACD 0.01 0.07
Stochastic Oscillator 1.52 0.11

Price Performance

Historical Comparison
LABT
MI

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

About MI NFT Limited

NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

Share on Social Networks: